Skip to main content
Caplight Logo









Oobli

Oobli

Private
Davis, CaliforniaConsumer & Commercehttps://oobli.com

Last Round

Series B

Extension

Feb 13, 2025

Total Funding Raised

$62.5M

Company Overview

Oobli operates in Consumer & Commerce and is based in Davis, California. Its latest recorded funding round was a Series B Extension round in February 2025.

Oobli is a food technology company that develops sweet protein-based sugar alternatives using precision fermentation to provide healthier, climate-friendly sweeteners for food and beverage products.

Sector

Consumer & Commerce

Verticals

Biotechnology, D2C Brands, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Oobli Comparables

Compare Oobli with similar companies based on industry and business-model similarity.

Oobli comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amai Proteins
87%
SweeGen
86%
Elo Life Systems
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Oobli Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 13, 2025
Series BMay 27, 2022
Series AJul 21, 2020
SeedMar 14, 2016
SeedOct 15, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jason Ryder

Founder & CTO

Founding Team

Ali M Wing

CEO

Executive Team

Naomi Sachs

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Oobli Investors

Notable investors and investment history

Oobli investors
InvestorRounds
B37 VenturesSeries B Extension, Series B
Bimbo VenturesSeries B
Evolv VenturesSeries B, Series A
Sucden VenturesSeries B Extension
Khosla VenturesSeries B Extension, Series B, Series A, Seed
Global Brain CorporationSeries B Extension, Series B
Ingredion VenturesSeries B Extension
Book a demo to see all 13 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Received multiple approvals including 'no questions' letters and GRAS statuses.

  • Mar 20, 2026

    Developing reduced-sugar beverages with SIG.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withOct 23, 2026

    Oobli partners with Cosun Ingredients to co-develop a sugar replacement system for chocolate products, pairing sweet proteins with chicory fiber, on Oct 23rd '26.

  • launchesOct 23, 2026

    In Oct '26, Oobli co-develops a sugar replacement system for chocolate with Cosun Ingredients, pairing sweet proteins with chicory fibre while expanding access to its monellin ingredient and Oobli Inside platform.

  • launchesOct 21, 2026

    Oobli makes Serendipity Berry Sweet Protein available now and features it in prototypes at SupplySide Global Booth #2213 in Nevada on Oct 28th-30th '26; the product is FDA GRAS-confirmed as a sweetener and holds FEMA GRAS status as a natural flavor.

  • launchesOct 21, 2026

    Oobli launches Oobli Inside(TM), a consumer-facing platform that identifies food and beverage products made with its non-GMO sweet proteins and helps consumers make healthier everyday choices, in Sep '26.

  • partners_withSep 8, 2026

    On Sep 8th '26 in Ohio, Oobli and NFL Alumni announce a strategic partnership to deliver national education initiatives at youth football camps, community events, Hall of Fame activities, and Super Week leading up to the 2027 Big Game in California.

Book a demo to see all news

For institutional investors. Book with your work email.

Oobli Filings

Explore SEC and related filing metadata, where available.

Oobli filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Oobli's valuation, stock price, and market status.

Is Oobli a public or private company?

Oobli is a private company.

What is the current stock price of Oobli?

Oobli is a private company, so its shares have no public market price. Caplight tracks Oobli's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Oobli worth (valuation)?

Valuation information for Oobli is not publicly available.

Can I buy Oobli stock?

Oobli shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Oobli's last funding round?

Oobli's most recent funding round was Series B Extension on February 13, 2025.

Who are the main investors in Oobli?

Key investors in Oobli include Evolv Ventures, Ingredion Ventures, IndieBio, Piva Capital.

Will Oobli IPO soon?

No public IPO plans have been announced for Oobli.

How can I track Oobli secondary market activity?

Caplight tracks bids, offers, and trades in Oobli's shares on secondary markets.

Firmographic Details

HeadquartersDavis, California
Employee Range34
Year Founded2014
Last FundingFeb 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?